Oaktree Specialty Lending Corp
OCSL Nasdaq Financials FY2021–FY2025
Last close · Oct 23, 2026
$11.44
0.1%What Oaktree Specialty Lending Corp does
No business description yet.
- Legal name
- Oaktree Specialty Lending Corp
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K · Nov 18, 2025
- Accession · CIK
- 0001414932-25-000022
0001414932
Revenue and margins
Oaktree Specialty Lending Corp had $317M of revenue in fiscal 2025, down 17.0% on the year before.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew −45.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Oaktree Specialty Lending Corp returned $159M to shareholders in fiscal 2025. The diluted share count rose 7.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Oaktree Specialty Lending Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $29.3M | $23.5M | $136M | $64.0M | $79.6M |
| Debt incl. finance leases | — | $1.3B | $1.6B | $1.6B | $1.5B |
| Debt / equity | — | 1.0x | 1.1x | 1.1x | 1.0x |
| Total assets | — | $2.6B | $3.2B | $3.2B | $3.0B |
| Total liabilities | — | $1.4B | $1.7B | $1.7B | $1.5B |
| Shareholders' equity | $1.3B | $1.2B | $1.5B | $1.5B | $1.5B |
| Net debt (− = net cash) | — | $1.3B | $1.5B | $1.6B | $1.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✓ | ✕ | ✓ |
| Debt fell relative to assets | — | — | ✕ | ✕ | ✓ |
| Current ratio rose | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✓ | ✓ | ✕ |
| F-score | — / 3 | — / 4 | 5 / 7 | 3 / 7 | 4 / 7 |
| Accruals ratio | — | 0.3% | −3.8% | 1.2% | −6.3% |
| Altman Z'' | — | — | — | — | — |
5 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $209M | $263M | $379M | $382M | $317M |
| Interest expense | $30.5M | $46.9M | $112M | $129M | $116M |
| Income tax | $0.7M | $1.3M | — | — | $0.1M |
| Net income | $237M | $29.2M | $117M | $57.9M | $33.9M |
| Diluted EPS | $4.39 | $0.48 | $1.63 | $0.72 | $0.39 |
| Diluted shares | 0.05B | 0.06B | 0.07B | 0.08B | 0.09B |
| Cash flow | |||||
| Cash from operations | −$231M | $22.4M | $229M | $19.1M | $228M |
| Share buybacks | $2.2M | $1.9M | $2.4M | $1.6M | $10.7M |
| Dividends paid | $79.9M | $115M | $180M | $177M | $148M |
| Dividends and buybacks | $82.0M | $117M | $182M | $178M | $159M |
| Balance sheet | |||||
| Cash and short-term investments | $29.3M | $23.5M | $136M | $64.0M | $79.6M |
| Total debt | — | $1.3B | $1.6B | $1.6B | $1.5B |
| Total assets | — | $2.6B | $3.2B | $3.2B | $3.0B |
| Total liabilities | — | $1.4B | $1.7B | $1.7B | $1.5B |
| Shareholders' equity | $1.3B | $1.2B | $1.5B | $1.5B | $1.5B |
| Margins | |||||
| Net margin | 113.3% | 11.1% | 30.9% | 15.2% | 10.7% |
| Returns | |||||
| Return on equity | 18.1% | 2.3% | 8.5% | 3.9% | 2.3% |
| Return on assets | — | 1.1% | 4.0% | 1.8% | 1.1% |
| Return on tangible equity | 18.1% | 2.3% | 7.7% | 3.9% | 2.3% |
| Growth | |||||
| Revenue growth | — | 25.4% | 44.5% | 0.6% | −17.0% |
| Net income growth | — | −87.7% | 301.5% | −50.6% | −41.4% |
| EPS growth | — | −89.1% | 239.6% | −55.8% | −45.8% |
| Share count change | — | 12.4% | 18.8% | 11.5% | 7.0% |
| Financial health | |||||
| Debt / equity | — | 1.0x | 1.1x | 1.1x | 1.0x |
| Quality scores | |||||
| Piotroski F-score | — | — | 5.0 | 3.0 | 4.0 |
| Accruals ratio | — | 0.3% | −3.8% | 1.2% | −6.3% |
Source: SEC EDGAR XBRL filings (CIK 0001414932). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
